Entera Bio Ltd. (ENTX) — Institutional Holders, Q2 2026

27 institutional investment managers reported a ENTX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $19.0M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ENTX in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

7

Added to

8

Trimmed

6

Sold out

6

Biggest buyers

  1. BVFNew · +2,425,000 sh+$4.3M
  2. Siren, L.L.C.New · +736,457 sh+$1.3M
  3. PNC FINANCIAL SERVICES GROUPAdded · +263,031 sh+$465.6K
  4. HRT FINANCIALAdded · +56,994 sh+$100.9K
  5. TWO SIGMA SECURITIESNew · +48,593 sh+$86.0K

Biggest sellers

  1. CITADEL ADVISORSTrimmed · -206,773 sh-$366.0K
  2. MARSHALL WACE, LLPSold out · -195,780 sh-$346.5K
  3. NORTHERNSold out · -146,854 sh-$259.9K
  4. XTX Topco LtdTrimmed · -111,063 sh-$196.6K
  5. RENAISSANCE TECHNOLOGIESTrimmed · -104,595 sh-$185.1K

ENTX 13F holders ranked 1–27 of 27

Institutional investors reporting a position in Entera Bio Ltd. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Knoll Capital Management#1 · 5,881,879 sh$10.4M0.0%
BVF#2 · 2,425,000 sh$4.3MNew
Siren, L.L.C.#3 · 736,457 sh$1.3MNew
RENAISSANCE TECHNOLOGIES#4 · 368,847 sh$652.9K-22.1%
Parkman Healthcare Partners#5 · 274,497 sh$485.9K-4.9%
PNC FINANCIAL SERVICES GROUP#6 · 273,031 sh$483.3K+2630.3%
Seven Fleet Capital Management#7 · 191,354 sh$338.7K-6.9%
HighTower Advisors#8 · 74,573 sh$132.9K+102.5%
HRT FINANCIAL#9 · 72,486 sh$128.0K+367.9%
Schonfeld Strategic Advisors#10 · 58,871 sh$104.2K+6.6%
TWO SIGMA SECURITIES#11 · 48,593 sh$86.0KNew
SIGNATURE ESTATE & INVESTMENT ADVISORS#12 · 47,328 sh$83.8K0.0%
CITADEL ADVISORS#13 · 38,804 sh$68.7K-84.2%
JPMORGAN CHASE#14 · 40,883 sh$67.5K+471.8%
Virtu Financial#15 · 36,921 sh$65.0KNew
GEODE CAPITAL MANAGEMENT#16 · 29,908 sh$52.9K+41.5%
DIADEMA PARTNERS#17 · 23,260 sh$41.2K0.0%
XTX Topco Ltd#18 · 20,559 sh$36.4K-84.4%
Gem Investment Advisors#19 · 19,135 sh$33.9K0.0%
JANE STREET GROUP#20 · 17,331 sh$30.7K-47.3%
SIMPLEX TRADING#21 · 15,698 sh$27.8KNew
SG Americas Securities#22 · 13,913 sh$25.0KNew
UBS Group AG#23 · 12,723 sh$22.5K+296.1%
Persistent Asset Partners Ltd#24 · 5,881 sh$10.4K0.0%
MORGAN STANLEY#25 · 500 sh$885.00+25.0%
BNP PARIBAS FINANCIAL MARKETS#26 · 400 sh$708.00New
GROUP ONE TRADING, L.P.#27 · 51 sh$90.000.0%

Funds that sold out of ENTX in Q2 2026 (6)

Held ENTX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held ENTX in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
MARSHALL WACE, LLP195,780 sh$217.3K
NORTHERN146,854 sh$163.0K
Point72 Asset Management, L.P.12,382 sh$13.7K
BANK OF AMERICA12,000 sh$13.3K
Caitong International Asset Management , Ltd20 sh$22.00
SBI Securities , Ltd.2 sh$2.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.